Drug Profile
DTP-HepB-Polio-Hib vaccine - Sanofi
Alternative Names: DTwP-HepB-Polio-Hib vaccine - Sanofi; Shan 6; Shan6Latest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Sanofi
- Developer Sanofi; Shantha Biotechnics
- Class Bacterial vaccines; Hepatitis B vaccines; Influenza virus vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 20 Nov 2021 Sanofi completes a phase III trial for Diphtheria, Tetanus, Pertussis, Hepatitis B (Prevention, In infants) in Thailand (PO)(NCT04429295)
- 29 Jul 2021 Registered for Diphtheria (In infants, Prevention) in India (IM) before July 2021
- 29 Jul 2021 Registered for Haemophilus infections (In infants, Prevention) in India (IM) before July 2021